Morpheus8 vs Sylfirm X

Independent side-by-side comparison with pricing, specs, and clinical evidence.

Last updated: 2026-04-09

Why This Comparison Matters

Morpheus8 and Sylfirm X sit in the same rf microneedling category but take different approaches. Morpheus8 (InMode) uses Fractional RF Microneedling with bipolar RF and burst mode while Sylfirm X (Benev) uses Pulsed-Wave RF Microneedling (dual continuous + pulsed modes). Both received FDA clearance (2020 and 2021 respectively) and both are actively sold in the US market. The decision between them is rarely about which is objectively better. It's about which fits your specific practice.

Physicians end up comparing these two devices when they're shopping in the $40,000-$60,000 to $30,000-$50,000 price range and want a category leader. Both devices are commonly recommended by sales reps from competing manufacturers, which means physicians often hear inflated claims about one and dismissive claims about the other. This comparison strips out the marketing and looks at pricing, mechanism, evidence, and practice fit side by side.

Side-by-Side Specifications

Morpheus8 Sylfirm X
Manufacturer InMode Benev
Technology Fractional RF Microneedling with bipolar RF and burst mode Pulsed-Wave RF Microneedling (dual continuous + pulsed modes)
Price (New) $40,000-$60,000 $30,000-$50,000
Price (Used) $25,000-$45,000 $12,000-$25,000
Treatment Time 15-60 minutes depending on area 20-30 minutes
Sessions 1-3 sessions 3 sessions over 6-8 weeks
Per Session $800-$2,500 $600-$1,500
Annual Consumables $3,000-$8,000 (tips) $2,000-$5,000
Annual Maintenance $2,000-$5,000 $2,000-$4,000
FDA Cleared Yes (2020) Yes (2021)

Technology

Morpheus8

Technology: Fractional RF Microneedling with bipolar RF and burst mode. Deepest RF microneedling penetration (up to 8mm with body tip). Subdermal fat remodeling + collagen induction.

Sylfirm X

Technology: Pulsed-Wave RF Microneedling (dual continuous + pulsed modes). First dual-mode RF microneedling platform combining continuous wave and pulsed wave RF. Claimed to treat rosacea and melasma through pulsed-wave targeting of vascular components, which traditional RF microneedling cannot address.

Pricing

Morpheus8

New: $40,000-$60,000. Used: $25,000-$45,000. Per session: $800-$2,500. Annual consumables: $3,000-$8,000 (tips). Annual maintenance: $2,000-$5,000.

Sylfirm X

New: $30,000-$50,000. Used: $12,000-$25,000. Per session: $600-$1,500. Annual consumables: $2,000-$5,000. Annual maintenance: $2,000-$4,000.

Clinical Evidence

Morpheus8

50+ published studies. Strong body of evidence for facial rejuvenation. Body application evidence is growing but thinner.

Sylfirm X

Strong Korean and Asian published evidence base. US peer-reviewed studies growing since 2021 clearance.

Treatment Experience

Morpheus8

15-60 minutes depending on area per session. Recommended protocol: 1-3 sessions. Treatment areas: Face, Neck, Body (abdomen, thighs, arms). Patients typically tolerate this platform well when operated by trained clinicians.

Sylfirm X

20-30 minutes per session. Recommended protocol: 3 sessions over 6-8 weeks. Treatment areas: Face, Neck, Body. Patient experience varies by operator training and settings.

Practice Fit

Morpheus8

Practices wanting the most recognized RF microneedling brand with body treatment capability. High-volume aesthetic practices where patient demand drives device selection.

Sylfirm X

Dermatology and med spa practices that treat melasma and rosacea alongside general RF microneedling. Practices wanting Korean-developed dual-wave capability at a mid-range price point.

Pros and Cons

Morpheus8 Pros

  • Deepest penetration depth in the category (4mm face, 8mm body)
  • Strong brand recognition (highest consumer search volume in RF microneedling)
  • Body treatment capability (unique among RF microneedling platforms)
  • Can be combined with other InMode platforms (BodyTite, FaceTite)

Morpheus8 Cons

  • 14 FDA adverse events in March 2026 alone (up from 3/mo baseline)
  • 9 thermal injury reports, 3 scarring reports in recent MAUDE data
  • Consumable tip costs are significant

Sylfirm X Pros

  • Dual wave mode adds melasma and rosacea capability
  • Lower capital cost than Morpheus8 or Potenza
  • Non-insulated needles with controlled thermal spread
  • Strong Korean clinical evidence base

Sylfirm X Cons

  • Pulsed wave clinical evidence is still maturing in the US
  • Benev is a distributor, not the original manufacturer (Viol is the OEM)
  • Brand recognition trails Morpheus8 in the US market

The Verdict

Choose Morpheus8 if your practice prioritizes InMode's ecosystem, brand recognition, or specific clinical advantages. Practices wanting the most recognized RF microneedling brand with body treatment capability. High-volume aesthetic practices where patient demand drives device selection. The pros that matter most: Deepest penetration depth in the category (4mm face, 8mm body); Strong brand recognition (highest consumer search volume in RF microneedling). The biggest tradeoff to accept: 14 FDA adverse events in March 2026 alone (up from 3/mo baseline).

Choose Sylfirm X if Benev's positioning fits better. Dermatology and med spa practices that treat melasma and rosacea alongside general RF microneedling. Practices wanting Korean-developed dual-wave capability at a mid-range price point. The pros that matter most: Dual wave mode adds melasma and rosacea capability; Lower capital cost than Morpheus8 or Potenza. The biggest tradeoff to accept: Pulsed wave clinical evidence is still maturing in the US.

For a practice with limited capital that needs maximum flexibility, used pricing tilts the math. Morpheus8 used units run $25,000-$45,000; Sylfirm X used units run $12,000-$25,000. For practices with strong patient flow already, the device that integrates with your existing platforms is usually the right answer even if its standalone specs are slightly weaker. For practices building a category from scratch, brand recognition and patient demand matter more than raw clinical specs. Look at which device patients are already asking for in your market before signing a contract.

Frequently Asked Questions

Which is more expensive, Morpheus8 or Sylfirm X?

Morpheus8 runs $40,000-$60,000 new and $25,000-$45,000 used. Sylfirm X runs $30,000-$50,000 new and $12,000-$25,000 used. Per-session pricing is $800-$2,500 for Morpheus8 and $600-$1,500 for Sylfirm X. Annual operating costs (consumables plus maintenance) typically run 5-15% of purchase price for both devices. The right financial comparison includes total cost of ownership over 5 years, not just sticker price.

Which has better clinical evidence, Morpheus8 or Sylfirm X?

Morpheus8 clinical evidence: 50+ published studies. Strong body of evidence for facial rejuvenation. Body application evidence is growing but thinner. Sylfirm X clinical evidence: Strong Korean and Asian published evidence base. US peer-reviewed studies growing since 2021 clearance. Evidence quality is not about study count alone. Look at sample sizes, blinded evaluators, independence from manufacturer funding, and outcome durability. Older devices in the same category usually have stronger evidence because they've been studied longer.

Is Morpheus8 or Sylfirm X more popular in dermatology practices?

Both Morpheus8 and Sylfirm X are commonly used in dermatology, plastic surgery, med spa practices. Market share in any given category shifts year to year. InMode and Benev both maintain active sales forces in the US. Ask other physicians in your specialty which platform they're using and why. Peer references in your local market matter more than national market share data.

Are there safety concerns with Morpheus8 or Sylfirm X?

Both devices are FDA cleared and have established safety profiles. Morpheus8 has these documented concerns: 14 FDA adverse events in March 2026 alone (up from 3/mo baseline). Sylfirm X has: Pulsed wave clinical evidence is still maturing in the US. Physicians should monitor FDA MAUDE reports for both devices before purchase. Adverse event trends matter because they signal problems that may not appear in marketing materials. Any device with a sudden spike in MAUDE filings deserves closer scrutiny.

Can I use Morpheus8 and Sylfirm X in the same practice?

Some practices run both devices, especially when they target different patient segments or treatment areas. The downside is duplicated training, parallel consumable inventories, and potential cannibalization between platforms. The upside is broader marketing claims and the ability to switch patients between platforms if one doesn't deliver expected results. Most practices choose one and commit to mastering it rather than splitting volume.

What's the resale value comparison between Morpheus8 and Sylfirm X?

Used Morpheus8 sells for $25,000-$45,000 on the secondary market. Used Sylfirm X sells for $12,000-$25,000. Resale values depend on age, software version, applicator condition, and remaining warranty. Devices with strong installed bases hold value better. Devices with active safety signals or declining manufacturer financial health depreciate faster. Resale value should be a factor in any device purchase, especially if practice plans might change in 3-5 years.